- Home
- MRNA vs VEEV Comparison
MRNA vs VEEV Comparison
Compare MRNA & VEEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- VEEV
- Stock Information
- Founded
- MRNA 2010
- VEEV 2007
- Country
- MRNA United States
- VEEV United States
- Employees
- MRNA N/A
- VEEV N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- VEEV Computer Software: Prepackaged Software
- Sector
- MRNA Health Care
- VEEV Technology
- Exchange
- MRNA Nasdaq
- VEEV Nasdaq
- Market Cap
- MRNA 34.6B
- VEEV 33.1B
- IPO Year
- MRNA 2018
- VEEV 2013
- Fundamental
- Price
- MRNA $54.82
- VEEV $217.09
- Analyst Decision
- MRNA Hold
- VEEV Buy
- Analyst Count
- MRNA 16
- VEEV 24
- Target Price
- MRNA $95.93
- VEEV $233.29
- AVG Volume (30 Days)
- MRNA 5.0M
- VEEV 742.6K
- Earning Date
- MRNA 11-07-2024
- VEEV 12-04-2024
- Dividend Yield
- MRNA N/A
- VEEV N/A
- EPS Growth
- MRNA N/A
- VEEV 12.96
- EPS
- MRNA N/A
- VEEV 3.75
- Revenue
- MRNA $5,050,000,000.00
- VEEV $2,573,649,000.00
- Revenue This Year
- MRNA N/A
- VEEV $16.85
- Revenue Next Year
- MRNA $5.29
- VEEV $11.98
- P/E Ratio
- MRNA N/A
- VEEV $57.88
- Revenue Growth
- MRNA N/A
- VEEV 15.29
- 52 Week Low
- MRNA $54.82
- VEEV $162.72
- 52 Week High
- MRNA $170.47
- VEEV $236.90
- Technical
- Relative Strength Index (RSI)
- MRNA 25.28
- VEEV 62.88
- Support Level
- MRNA $55.70
- VEEV $209.01
- Resistance Level
- MRNA $59.73
- VEEV $218.66
- Average True Range (ATR)
- MRNA 2.17
- VEEV 3.44
- MACD
- MRNA 0.29
- VEEV 0.81
- Stochastic Oscillator
- MRNA 0.00
- VEEV 91.45
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About VEEV Veeva Systems Inc.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.